Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers
In Brief: Garb Raps “Hostility Of Executive Branch”; Hew Considers Allowing Grants For Industry
New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors
“Dog And Pony Show” At FCRF For NCAB OFF
Congress Asked To Equalize Cuts, Add $20 million For Centers
ACS Says New Tax Policy Hurts Charity Funds
Study Finds Short Term Tests Predict Carcinogenicity
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
